16782729

Source:http://linkedlifedata.com/resource/pubmed/id/16782729

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0205210, umls-concept:C0334094, umls-concept:C0441655, umls-concept:C0681842, umls-concept:C0872169, umls-concept:C1300072, umls-concept:C1336117, umls-concept:C1521733
pubmed:issue	7
pubmed:dateCreated	2006-8-4
pubmed:abstractText	To predict a malignant grade of lung cancer by fluorodeoxyglucose positron emission tomography (FDG-PET) scanning, we investigated the correlation between FDG uptake and pathological tumor stage, proliferative activities determined by Ki-67 and cyclin D1, and an alteration of p53, in clinical stage (c-stage) IA lung adenocarcinomas.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclin D1, http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18, http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0368-2811
pubmed:author	pubmed-author:EbiharaAkinoriA, pubmed-author:GoyaTomoyukiT, pubmed-author:KobayashiToshiakiT, pubmed-author:NarukeTsuguoT, pubmed-author:NomoriHiroakiH, pubmed-author:OhtsukaTakashiT, pubmed-author:OrikasaHidekiH, pubmed-author:UnoKimiichiK, pubmed-author:WatanabeKen-ichiK, pubmed-author:YamazakiKazutoK
pubmed:issnType	Print
pubmed:volume	36
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	403-9
pubmed:meshHeading	pubmed-meshheading:16782729-Adenocarcinoma, pubmed-meshheading:16782729-Adult, pubmed-meshheading:16782729-Aged, pubmed-meshheading:16782729-Aged, 80 and over, pubmed-meshheading:16782729-Cell Proliferation, pubmed-meshheading:16782729-Cyclin D1, pubmed-meshheading:16782729-Female, pubmed-meshheading:16782729-Fluorodeoxyglucose F18, pubmed-meshheading:16782729-Genes, Tumor Suppressor, pubmed-meshheading:16782729-Humans, pubmed-meshheading:16782729-Ki-67 Antigen, pubmed-meshheading:16782729-Lung Neoplasms, pubmed-meshheading:16782729-Male, pubmed-meshheading:16782729-Middle Aged, pubmed-meshheading:16782729-Neoplasm Staging, pubmed-meshheading:16782729-Positron-Emission Tomography, pubmed-meshheading:16782729-Predictive Value of Tests, pubmed-meshheading:16782729-Radiopharmaceuticals, pubmed-meshheading:16782729-Tumor Suppressor Protein p53
pubmed:year	2006
pubmed:articleTitle	[F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
pubmed:affiliation	Department of Thoracic Surgery, Saiseikai Central Hospital, Tokyo, Japan.
pubmed:publicationType	Journal Article